Pacira BioSciences, Inc. (PCRX) — Financial Flexibility Index
Pacira BioSciences, Inc. (PCRX) has a Financial Flexibility Index of 0.05x as of March 2026. Free cash flow of $28.40 Million (operating CF $25.68 Million minus capex $2.72 Million) represents 0% of total liabilities ($554.64 Million). Also explore net asset momentum of Pacira BioSciences, Inc. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pacira BioSciences, Inc. Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Pacira BioSciences, Inc. across 18 annual periods. Check PCRX capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Pacira BioSciences, Inc. (2008–2025)
Year-by-year free cash flow to debt coverage for Pacira BioSciences, Inc.. For the full company profile including market capitalisation, see how much is Pacira BioSciences, Inc. worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | $167.33 Million | $151.99 Million | $571.81 Million | ▲ +13.4% |
| 2024 | 0.26x | $200.03 Million | $189.39 Million | $775.17 Million | ▲ +7.0% |
| 2023 | 0.24x | $169.81 Million | $154.65 Million | $704.26 Million | ▲ +24.6% |
| 2022 | 0.19x | $175.35 Million | $145.27 Million | $906.19 Million | ▲ +51.7% |
| 2021 | 0.13x | $171.58 Million | $125.72 Million | $1.34 Billion | ▼ -27.3% |
| 2020 | 0.18x | $114.83 Million | $77.03 Million | $654.83 Million | ▲ +3.5% |
| 2019 | 0.17x | $80.68 Million | $70.52 Million | $476.12 Million | ▼ -1.6% |
| 2018 | 0.17x | $63.38 Million | $48.87 Million | $368.13 Million | ▲ +62.1% |
| 2017 | 0.11x | $37.05 Million | $17.79 Million | $348.89 Million | ▼ -68.5% |
| 2016 | 0.34x | $58.16 Million | $33.45 Million | $172.49 Million | ▼ -17.8% |
| 2015 | 0.41x | $70.27 Million | $29.00 Million | $171.23 Million | ▲ +34.2% |
| 2014 | 0.31x | $47.36 Million | $25.47 Million | $154.93 Million | ▲ +229.2% |
| 2013 | -0.24x | $-30.42 Million | $-43.22 Million | $128.57 Million | ▲ +78.9% |
| 2012 | -1.12x | $-51.87 Million | $-70.13 Million | $46.20 Million | ▼ -194.9% |
| 2011 | -0.38x | $-24.83 Million | $-31.00 Million | $65.22 Million | ▼ -141.7% |
| 2010 | -0.16x | $-18.11 Million | $-24.88 Million | $114.94 Million | ▲ +31.2% |
| 2009 | -0.23x | $-15.33 Million | $-20.84 Million | $66.90 Million | ▲ +57.8% |
| 2008 | -0.54x | $-23.35 Million | $-29.19 Million | $43.05 Million | — |